06 January 2025
We are excited to offer an exceptional PostDoc grant opportunity in the cutting-edge field of parapoxvirus-based cancer vaccines. This unique chance offers high-class talents the opportunity to execute their postdoctoral project proposal in the state-of-the-art scientific environment of the DNA Virus team at ViraTherapeutics, a subsidiary of Boehringer Ingelheim, located in Innsbruck, Austria for up to three years.
Cancer immunotherapy focuses on harnessing the patient's immune system to generate durable responses against malignancies. Common approaches involve the use of tumor-specific antigenic sequences, delivered through various platforms such as DNA, RNA, peptides, or virus-based cancer vaccine platforms. The success of a cancer vaccine depends on factors like the design of the antigenic sequence, the chosen platform, and patient-related factors.
The DNA virus team of Boehringer Ingelheim is specifically exploring the use of poxviruses as a cancer vaccine platform, and invites proposals for the following question:
With the goal to optimize a parapoxvirus-based cancer vaccine platform, how do you propose to understand the mechanisms driving the induction of an anti-cancer immune response and the key factors impacting the efficacy of such a vaccine?
Please submit your complete application package, which includes your project plan, CV, publication list, and letters of recommendation, on our platform, opnMe.com. A panel of highly distinguished ViraTherapeutics scientists are eagerly waiting to review your application.
If selected, you will embark on a unique and fully supported PostDoc position, where you can pursue your own groundbreaking research project. As a valued member of the research team, you will have access to a fully equipped laboratory in a state-of-the-art research facility, mentoring from experts, opportunity to attend international conferences and to publish in high-ranking journals.
Apply soon as your applications can only be accepted if they arrive by March 05, 2025, 11:59 pm PST.
Subscribe to our newsletter to stay updated as we add new opportunities to opnMe.com.
About our opn2TALENTS program:
Would you like your PostDoc project funded, conducting your studies at a leading pharmaceutical company, benefiting from a fully resourced and well-funded research environment? With opn2TALENTS, we provide a unique opportunity for high class talents to pitch their scientific ideas for a well-defined research question. The winner will have the opportunity to execute their postdoctoral research at Boehringer Ingelheim. Please note that the offered position covers a duration of three years in the DNA Virus team at ViraTherapeutics, a subsidiary of Boehringer Ingelheim, in Innsbruck, Austria.
About opnMe:
opnMe.com, the open innovation portal of Boehringer Ingelheim, aims to accelerate research initiatives to enable new insights of disease biology in areas of high unmet medical need by sharing well-characterized molecules for free and offer collaborations for science. Our newly launched program, opn2TALENTS postdoc grants awards opportunities for high class talents to pitch their scientific ideas and approaches for a well-defined research question to conduct their research at one of our discovery research sites in Germany, Austria, or the US.